Check back here often to see Cellecta’s event schedule. We are quite active in the scientific community.
May 2012
GTC 3rd RNAi Research & Therapeutics Conference, Omics Evolution Summit 2012 (Exhibit, Speaker, Poster)
May 29-31, Boston, MA
“RNAi Genetic Screening for Drug Target Discovery”
When: Thursday, May 31, 10:15 – 10:40 am
Presented by: Dr. Paul Diehl, Director of Business Development
Poster Presentation:
“RNAi Genetic Screening for Drug Target Discovery”
Presented by: Dr. Paul Diehl, Director of Business Development
April 2012
BIO-IT World 2012 (Poster)
April 24-26, Boston, MA
Poster Presentation:
“RNAi Genetic Screening for Drug Target Discovery”
Presented by: Mikhail Makhanov, Research Scientist, Bioinformatics
Genomics Research 2012 (Exhibit# 2, Invited Speaker, Poster)
April 19-20, Boston, MA
“RNAi Genetic Screening for Drug Target Discovery”
When: Thursday, April 19, 12:15 – 12:45 pm
Presented by: Dr. Alex Chenchik, President/CEO/CSO
Poster Presentation:
“RNAi Genetic Screening for Drug Target Discovery: Viability screens in leukemic and breast cancer cells using Open Source pooled lentiviral shRNA libraries”
Presented by: Dr. Alex Chenchik, President/CEO/CSO
March 2012
AACR Annual Meeting, 2012 (Exhibit# 2815, Poster)
March 31 – April 4, 2012, Chicago, IL
Add to My AACR Show Planner
Poster Presentation:
“RNAi Genetic Screening for Drug Target Discovery”
Add to My AACR Itinerary at aacr.org
When: Sunday, April 01, 2012, 1:00 pm – 5:00 pm
Poster: PO.ET03.05. New Models, Screens, and Diagnostics for Target Identification
McCormick Place West (Hall F), Section 33, Poster 3
Presented by: Dr. Alex Chenchik, President/CEO/CSO
Targets and Tools 2012, Oncology Drug Discovery (Talk, Poster)
Mar 20-21, 2012, Berlin, Germany
“RNAi Genetic Screening for Drug Target Discovery”
When: Tuesday, Mar. 20, 12:45 – 1:15pm
Presented by: Dr. Paul Diehl, Director of Business Development
Poster Presentation:
“RNAi Genetic Screening for Drug Target Discovery”
Presented by: Dr. Paul Diehl, Director of Business Development
February 2012
SLAS 2012 (Exhibit# 648, Invited Speaker, Poster)
Feb 4-8, 2012, San Diego, CA
Podium Presentation:
“Viability screens in leukemic and breast cancer cells with pooled lentiviral shRNA libraries identify potential therapeutic targets and synergistic lethal interactions.”
When: Tuesday, Feb. 7, 4:30 – 5:00pm
Where: SDCC, Ballroom 6C
Session: RNAi Screening Technologies
Presented by: Dr. Alex Chenchik, President/CEO/CSO
Read the abstract and add it to your calendar, via www.slas2012.org
Poster Presentation:
“HT Screening for bioactive peptides that increase radiation tolerance using a pooled lentiviral peptide scanning library.”
When: Tuesday, Feb. 7, 1:00 – 3:00pm
Poster Sequence #: TP120
Track Title: Track 3 – High Throughput Technologies
Presented by: Dr. Alex Chenchik
December 2011
ASCB 2011 (Exhibit# 901, Tutorial, Poster)
Dec 3-7, 2011, Denver, CO
“Open-Source RNAi Genetic Screen Platform: Discovery of Drug Targets in Cancer Cell Models”
When: Monday, Dec. 5, 6:45 – 8:15pm
Where: Room 109
Hors D’oeuvres and light dinner buffet
Presented by: Dr. Paul Diehl
Poster Presentation:
“Viability screens in cancer cells with pooled shRNA libraries identify potential therapeutic targets and synergistic lethal interactions.”
When: Tuesday, Dec. 6, 2:00 – 3:30pm
Where: Board #B862, Exhibit Hall ABEF, Presentation# 1895
Presented by: Karim Hyder
November 2011
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics(Poster)
Nov 12-16, 2011, San Francisco, CA
Poster Presentation:
“Identification of potential cancer drug targets using HT RNAi screening with pooled shRNA libraries”
Zing Cancer Conference 2011 (Poster)
Nov 9-13, 2011, Xcaret, Mexico
Poster Presentation:
“Viability screens in cancer cells with pooled shRNA libraries identify potential therapeutic targets and synergistic lethal interactions”
NCRI Cancer Conference (Poster)
Nov 6-9, 2011, Liverpool, England
Poster Presentation:
“Viability screens in cancer cells with pooled shRNA libraries identify potential therapeutic targets and synthetic lethal interactions”
Where: Poster# 162
Presented by: Dr. Paul Diehl
Discovery on Target 2011 (Exhibit# 6)
Nov 2-4, 2011, Boston, MA
October 2011
The 6th Annual Peptide Therapeutics Symposium (Poster)
Oct 20-21, 2011, Salk Institute, La Jolla, CA
Poster Presentation:
“HT Screening for bioactive peptides that increase radiation tolerance using a pooled lentiviral peptide scanning library”
AACR Translation of the Cancer Genome: Scientific, Clinical, and Operational Challenges (Talk, Poster)
Oct 15-18, 2011, San Francisco, CA
Poster Presentation:
“Viability screens in leukemic and breast cancer cells with pooled lentiviral shRNA libraries identify potential therapeutic targets and synergistic lethal interactions”
12th International Congress of Human Genetics (ICHG) and the 61st ASHG Annual Meeting (Exhibit# 1425, Workshop, Poster)
Oct 11-15, 2011, Quebec, Canada
“Open-Source RNAi Genetic Screen Platform: Discovery of Drug Targets in Cancer Cell Models”
When: Friday, Oct. 14, 12:30 – 2:00pm
Where: Room 523, Level 5
Presented by: Dr. Paul Diehl
Link to ICHG/ASHG Schedule
Poster Presentation:
“Viability Screens with Pooled shRNA Libraries Identify Novel and Synthetically Lethal Anti-Cancer Targets”
When: Wednesday, Oct. 12, 3:00 – 4:00pm
Where: Poster #1210W, Level 2
Presented by: Dr. Paul Diehl
Academic Screening Workshop (Panel, Poster)
Oct 6-7, 2011 – Bridgewater, NJ
Panel: RNAi Technologies, Alex Chenchik, Cellecta, Inc.
Poster Presentation:
“Viability Screens with Pooled shRNA Libraries Identify Novel and Synthetically Lethal Anti-Cancer Targets”
September 2011
AACR Frontiers in Basic Cancer Research (Poster)
Sept 15-18, 2011, San Francisco, CA
Poster Presentation:
“Viability Screens with Pooled shRNA Libraries Identify Novel and Synthetically Lethal Anti-Cancer Targets”
Where: Poster #A36
Presented by: Dr. Kyle Bonneau
Sept 10-13, 2011 – The EMBO Meeting (Poster)
Our President/CEO presents poster #C194 on “Viability screens in cancer cells with pooled shRNA libraries identify potential therapeutic targets and synergistic lethal interactions” in Vienna, Austria.
Sept 8-9, 2011 – RNAi Europe (Poster)
Our President/CEO presents a poster on “Identification of potential cancer drug targets using HT RNAi screening with pooled shRNA libraries” in Munich, Germany.
August 2011
Aug 3, 2011 – Illumina Bay Area User Group Meeting (PDF)
June 2011
June 27-30, 2011 – BIO 2011 International Convention
Meet with our President/CEO and Director of Business Development at BIO 2011.
May 2011
May 15-21, 2011 – Gordon Conference – Antimicrobial Peptides (Poster)
Our President/CEO presents a poster on HT Screening for Bioactive Peptides that confer Radiation Resistance at the Gordon Conference in Barga, Italy.
May 2-3, 2011 – Stanford CCSB Annual Symposium (Poster)
Our President/CEO presents findings from RNAi screening for cancer drug targets at the Stanford CCSB Annual Symposium on Systems Biology of Cancer.
April 2011
Apr 28-29, 2011 – 6th Annual SBIR ASSETs Forum (Poster)
Cellecta presents its capabilities at the 6th Annual SBIR ASSETs Forum in Boston.
Apr 26-27, 2011 – RNAi World Congress (Poster)
Cellecta presents Poster #103 at the RNAi World Congress in Boston.
Apr 20, 2011 – Abbott/UMass Vendor Show (Seminar, Poster)
Cellecta exhibits and gives a seminar at the Abbott Pharmaceuticals/UMass Medical School Vendor Show.
Apr 12-14, 2011 – BioTrinity 2011
At the BioTrinity Partnering Conference in the UK, we meet with potential partners.
Apr 02-06, 2011 – AACR 2011 (Exhibit, Poster)
Cellecta has an exhibit booth and presents a poster at AACR 2011 in Orlando, FL.
March 2011
Mar 27-31, 2011 – SBS 2011 (Talk, Exhibit, Tutorial, Poster)
Cellecta presents a talk, tutorial, and poster, and has an exhibit booth at SBS 2011 in Orlando, FL.
Mar 14-16, 2011 – BIO-Europe Spring 2011
Our Director of Business Development met with potential partners at BIO-Europe Spring in Milan, Italy.
